Compounds > fusarium
Page last updated: 2024-08-21

fusarium and 2019 Novel Coronavirus Disease

fusarium has been researched along with 2019 Novel Coronavirus Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Aboutalebian, S; Ahsaniarani, AH; Arani, SS; Erami, M; Ganjizadeh, M; Hashemi Hezaveh, SJ; Matini, AH; Mirhendi, H; Momen-Heravi, M1
Blaize, M; Fekkar, A; Lampros, A; Monsel, A; Poignon, C; Vezinet, C1
Alshaya, OA; Alshehri, SD; Saleh, RA1

Other Studies

3 other study(ies) available for fusarium and 2019 Novel Coronavirus Disease

ArticleYear
Invasive
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Antifungal Agents; COVID-19; Fusariosis; Fusarium; Humans; Sequence Analysis, DNA

2023
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:11

    Topics: Antifungal Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Fusariosis; Fusarium; Humans; Immunocompetence; Intubation, Intratracheal; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020
Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection.
    The American journal of case reports, 2021, Aug-10, Volume: 22

    Topics: Adult; Amphotericin B; Antifungal Agents; Chemical and Drug Induced Liver Injury; COVID-19; Female; Fusarium; Humans; SARS-CoV-2; Sepsis; Voriconazole

2021